GAMCO Investors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRRA
GAMCO Investors's SRRA Position: Q3 2022 in Review
GAMCO Investors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 53,091 shares — an estimated $2.92M sold.
GAMCO Investors first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $2.92M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- GAMCO Investors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- GAMCO Investors sold 53,091 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $2.92M.
- GAMCO Investors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
- GAMCO Investors's Sierra Oncology, Inc. Common Stock position peaked at $2.92M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on GAMCO Investors's 13F filing for Q3 2022, filed 10 Nov 2022.